Abel Hall LLC
RMD icon

Abel Hall LLC’s ResMed RMD Stock Holding History

Abel Hall LLC’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$214K Buy
+970
New +$212K 0.04% 659

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
Aware Super
Aware Super Sydney, Australia $7.51B AUM
Washington Trust Advisors
Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
UniSuper Management
UniSuper Management Melbourne, Victoria, Australia $20.4B AUM 33.79% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Abel Hall LLC's RMD Position: Q3 2026 in Review

Abel Hall LLC opened a new position in ResMed (RMD) in Q3 2026: 970 shares worth $214K. The stake represents 0.04% of the portfolio and ranks #659 among its holdings.

288 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Abel Hall LLC held 970 shares of ResMed worth $214K as of Q3 2026.
  • ResMed was a new Abel Hall LLC position in Q3 2026.
  • ResMed made up 0.04% of Abel Hall LLC's portfolio in Q3 2026, its #659 holding.
  • 288 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.